The pharmaceutical company Gilead has announced that its new pre-exposure prophylactic (PrEP) injectable medication has passed a Phase III clinical trial demonstrating its safety and effectiveness ...
The Food and Drug Administration on Wednesday approved Gilead's twice-yearly antiviral injection for preventing HIV — a milestone that the company and some experts say could help bring the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results